£995 / $1740 / €1245
In today’s competitive and challenging medical device market the need to stay in touch with the latest corporate twists and turns grows ever greater. With cardiology devices taking a more important role in controlling the world’s biggest cause of death, business planners, marketers and commercial executives must know the developments which could influence their decisions.
Finding precisely that information in a world suffering from information overload is no easy task. That is why Espicom is introducing Cardiology Devices. No longer will you have to waste time searching through many and varied sources and publications to keep up to date.
Combined information for a complete market view
Combining data from Espicom’s leading medical information services and reports, this series provides a regularly-updated view of the companies, products, research and players – all in one convenient and easy-to-use online service.
Share information with the whole company
Best of all, Cardiology Devices can be shared with colleagues throughout your organisation with our cost-effective and flexible distribution packages.
In today’s highly competitive world of cardiology it pays to know the company, research and product developments which are shaping the market
CARDIOLOGY DEVICES ONLINE
Focused intelligence in a world of information overload
Driven by favourable demographic trends and product innovation, the global cardiology market is set for growth. Cardiovascular disease is the world’s leading health problem. In the developed world, its prevalence is linked to an ageing population and an increasingly unhealthy lifestyle, with risk factors including lack of exercise, obesity and smoking. Its reach is global, and major emerging economies such as Russia and India have significant levels of cardiovascular disease.
The impact of disease diagnosis and management on health costs is significant and health payers are increasingly looking to prevention rather than cure. However, when a cure is needed, the cardiology industry is under increasing pressure to prove not only effectiveness but beneficial economic outcomes. The issue of cost/benefit which, for example, affected the drug-eluting stent market is a timely reminder that, in future, industry has to meet more than safety and efficacy criteria.
The cardiology sector is characterised by advanced product innovation. Following positive clinical experience the rapidly developing market for artificial hearts is being closely watched. As eagerly awaited, although not without controversy, is the introduction of bioresorbable stents which are expected to move the sector forward.
Consolidation in the cardiology sector continues to alter the corporate landscape. The acquisition of Guidant by Boston Scientific may have made the headlines, but smaller, innovative developers continue to be bought by the major players as a means of fast track market entry. The big five may dominate the market, but the development sector is strong and vigorous. Will this consolidation continue or will developer companies be increasingly tempted to go it alone?
COMPANIES COVERED IN CARDIOLOGY DEVICES
Cardiology Devices answers key business questions
This unique business information service provides answers to key cardiology industry questions such as...
Cost-effective information for the whole organisation
Cardiology Devices is a business intelligence service with uses and applications throughout the organisation. It is particularly useful for management needing to stay informed of competitor moves, establish market plans and identify licensing deal opportunities.
Espicom has a number of flexible and tailored distribution licences available to suit every business need and budget.
Contact sales today to find out more and arrange an online demonstration at email@example.com alternatively you can use use our contact us page.